Correlation Between Spyre Therapeutics and 512807AN8

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and 512807AN8 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and 512807AN8 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and LAM RESH P, you can compare the effects of market volatilities on Spyre Therapeutics and 512807AN8 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 512807AN8. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 512807AN8.

Diversification Opportunities for Spyre Therapeutics and 512807AN8

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Spyre and 512807AN8 is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and LAM RESH P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LAM RESH P and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 512807AN8. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LAM RESH P has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 512807AN8 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and 512807AN8

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the 512807AN8. In addition to that, Spyre Therapeutics is 24.58 times more volatile than LAM RESH P. It trades about -0.02 of its total potential returns per unit of risk. LAM RESH P is currently generating about 0.0 per unit of volatility. If you would invest  9,872  in LAM RESH P on September 5, 2024 and sell it today you would earn a total of  4.00  from holding LAM RESH P or generate 0.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy89.6%
ValuesDaily Returns

Spyre Therapeutics  vs.  LAM RESH P

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
LAM RESH P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LAM RESH P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 512807AN8 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Spyre Therapeutics and 512807AN8 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and 512807AN8

The main advantage of trading using opposite Spyre Therapeutics and 512807AN8 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 512807AN8 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 512807AN8 will offset losses from the drop in 512807AN8's long position.
Spyre Therapeutics vs. Western Union Co
Spyre Therapeutics vs. Freedom Bank of
Spyre Therapeutics vs. Univest Pennsylvania
Spyre Therapeutics vs. NH Foods Ltd
The idea behind Spyre Therapeutics and LAM RESH P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
512807AN8 vs. Spyre Therapeutics
512807AN8 vs. Shake Shack
512807AN8 vs. American Hotel Income
512807AN8 vs. Ardelyx
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
CEOs Directory
Screen CEOs from public companies around the world


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY